AsOf

Recorded or changed on this day 2026-11-08

2,451–2,500 of 46,541 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 5,180,000,000 United States dollar
Amgen quarterly revenue: 5,180,000,000 United States dollar, claim clm_F203C4084F80 · ended · superseded by clm_FE2BDD289F38 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · revenue · 33,424,000,000 United States dollar
Amgen revenue: 33,424,000,000 United States dollar, claim clm_F31DA2CA4F3F · ended · superseded by clm_3DD4895A6205 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 1,466,000,000 United States dollar
Amgen quarterly operating income: 1,466,000,000 United States dollar, claim clm_F42B8D164D66 · ended · superseded by clm_C47F1D4F30C5 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Amgen · SEC CIK · 0000318154
Amgen SEC CIK: 0000318154, claim clm_F44BD9859244 · valid · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 88,720,000,000 United States dollar
Amgen total assets: 88,720,000,000 United States dollar, claim clm_F5CDB4E2EE9B · ended · superseded by clm_E898DB814445 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 10,959,000,000 United States dollar
Amgen total equity: 10,959,000,000 United States dollar, claim clm_F743BC59372A · ended · superseded by clm_6140719BE0F5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 30,133,000,000 United States dollar
Amgen total equity: 30,133,000,000 United States dollar, claim clm_F743D4B5E033 · ended · superseded by clm_99201951EE61 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 2,047,000,000 United States dollar
Amgen quarterly operating income: 2,047,000,000 United States dollar, claim clm_F7A83EC1A298 · ended · superseded by clm_DD5E7F4FA2BB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 22,339,000,000 United States dollar
Amgen total equity: 22,339,000,000 United States dollar, claim clm_F7BBC59E66C1 · ended · superseded by clm_70DC668489EA · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 2,591,000,000 United States dollar
Amgen quarterly operating income: 2,591,000,000 United States dollar, claim clm_F7F0878C88D4 · ended · superseded by clm_4DB5BAF9C86F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 90,883,000,000 United States dollar
Amgen total assets: 90,883,000,000 United States dollar, claim clm_F88E6D123694 · ended · superseded by clm_EE06CBFC7149 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 28,682,000,000 United States dollar
Amgen total equity: 28,682,000,000 United States dollar, claim clm_F89E040E0B16 · ended · superseded by clm_F743D4B5E033 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 6,528,000,000 United States dollar
Amgen cash and equivalents: 6,528,000,000 United States dollar, claim clm_F90753F8299C · ended · superseded by clm_2C58ADDE4DED · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 534,199,933 shares
Amgen shares outstanding: 534,199,933 shares, claim clm_F932B282715C · ended · superseded by clm_178FD19F2105 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 9,129,000,000 United States dollar
Amgen cash and equivalents: 9,129,000,000 United States dollar, claim clm_F9355A194FAC · ended · superseded by clm_93389ECFE0A1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 21,728,000,000 United States dollar
Amgen total equity: 21,728,000,000 United States dollar, claim clm_F959576F5D57 · ended · superseded by clm_CC7EBB14F5AA · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 3,392,000,000 United States dollar
Amgen cash and equivalents: 3,392,000,000 United States dollar, claim clm_FA4F80522690 · ended · superseded by clm_B0CE0DC6AD30 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 6,037,000,000 United States dollar
Amgen cash and equivalents: 6,037,000,000 United States dollar, claim clm_FAAD62580296 · ended · superseded by clm_3D6D73A86504 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 90,907,000,000 United States dollar
Amgen total assets: 90,907,000,000 United States dollar, claim clm_FB713317C6E9 · ended · superseded by clm_F88E6D123694 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 9,087,000,000 United States dollar
Amgen cash and equivalents: 9,087,000,000 United States dollar, claim clm_FB8BB664393E · ended · superseded by clm_3796FE9524B2 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 599,701,222 shares
Amgen shares outstanding: 599,701,222 shares, claim clm_FC64A72BD0A5 · ended · superseded by clm_C38259D1A5D3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 48,871,000,000 United States dollar
Amgen total assets: 48,871,000,000 United States dollar, claim clm_FCCCD0433A56 · ended · superseded by clm_EEC207B785D0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 39,629,000,000 United States dollar
Amgen total assets: 39,629,000,000 United States dollar, claim clm_FD45F1550892 · ended · superseded by clm_A1DE406B5E7E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 8,149,000,000 United States dollar
Amgen quarterly revenue: 8,149,000,000 United States dollar, claim clm_FD554405E740 · ended · superseded by clm_DF01174105A5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 5,031,000,000 United States dollar
Amgen quarterly revenue: 5,031,000,000 United States dollar, claim clm_FE2BDD289F38 · ended · superseded by clm_C0A999C2E5DE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 754,126,197 shares
Amgen shares outstanding: 754,126,197 shares, claim clm_FFC4D3147C5E · ended · superseded by clm_C9B23C443A68 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amphenol · quarterly operating income · 267,821,000 United States dollar
Amphenol quarterly operating income: 267,821,000 United States dollar, claim clm_003887265220 · ended · superseded by clm_CBD41E3F6C47 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amphenol · total assets · 7,027,000,000 United States dollar
Amphenol total assets: 7,027,000,000 United States dollar, claim clm_00845BF47D58 · ended · superseded by clm_B38424C2B605 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amphenol · quarterly revenue · 2,015,300,000 United States dollar
Amphenol quarterly revenue: 2,015,300,000 United States dollar, claim clm_00E6A05A6F38 · ended · superseded by clm_F56819ACD83F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amphenol · shares outstanding · 309,465,458 shares
Amphenol shares outstanding: 309,465,458 shares, claim clm_01468171F8CD · ended · superseded by clm_4E1F3E9FD21D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amphenol · shares outstanding · 173,552,423 shares
Amphenol shares outstanding: 173,552,423 shares, claim clm_01F732D094CF · ended · superseded by clm_879ADEF52439 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Amphenol · total assets · 47,021,800,000 United States dollar
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amphenol · shares outstanding · 598,185,235 shares
Amphenol shares outstanding: 598,185,235 shares, claim clm_02812CE0E35F · ended · superseded by clm_6D9312BD9B82 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amphenol · total equity · 3,065,100,000 United States dollar
Amphenol total equity: 3,065,100,000 United States dollar, claim clm_03ED4E9E5BEF · ended · superseded by clm_C4961D0E0FCE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amphenol · cash and equivalents · 998,300,000 United States dollar
Amphenol cash and equivalents: 998,300,000 United States dollar, claim clm_03FDAFE9F0D8 · ended · superseded by clm_846CC19C7416 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amphenol · net income · 1,902,300,000 United States dollar
Amphenol net income: 1,902,300,000 United States dollar, claim clm_04AB6A905827 · ended · superseded by clm_29F763D5FB83 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amphenol · total equity · 5,945,900,000 United States dollar
Amphenol total equity: 5,945,900,000 United States dollar, claim clm_05903AC73254 · ended · superseded by clm_F57B39698498 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amphenol · operating income · 751,678,000 United States dollar
Amphenol operating income: 751,678,000 United States dollar, claim clm_0619A179BC76 · ended · superseded by clm_0B5D8560AD7C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amphenol · shares outstanding · 307,664,328 shares
Amphenol shares outstanding: 307,664,328 shares, claim clm_06298A4DB698 · ended · superseded by clm_E9A5CF2BB2B2 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amphenol · quarterly operating income · 408,200,000 United States dollar
Amphenol quarterly operating income: 408,200,000 United States dollar, claim clm_065B5367C6ED · ended · superseded by clm_3CE01136DEBF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amphenol · total equity · 7,513,700,000 United States dollar
Amphenol total equity: 7,513,700,000 United States dollar, claim clm_0674EA507E6E · ended · superseded by clm_E1DFC31FE84B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amphenol · quarterly net income · 1,245,700,000 United States dollar
Amphenol quarterly net income: 1,245,700,000 United States dollar, claim clm_069658D29421 · ended · superseded by clm_920C4B4F1EE3 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Amphenol · registrant name · AMPHENOL CORP /DE/
Amphenol registrant name: AMPHENOL CORP /DE/, claim clm_06F93FD2A8A5 · valid · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amphenol · net income · 650,500,000 United States dollar
Amphenol net income: 650,500,000 United States dollar, claim clm_078972488C41 · ended · superseded by clm_589509607E6C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amphenol · quarterly operating income · 224,013,000 United States dollar
Amphenol quarterly operating income: 224,013,000 United States dollar, claim clm_07C97BFD51E9 · ended · superseded by clm_C3F052BA0DB8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amphenol · total equity · 3,704,200,000 United States dollar
Amphenol total equity: 3,704,200,000 United States dollar, claim clm_082EAFF20C56 · ended · superseded by clm_82CCCCBFD222 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amphenol · total assets · 3,219,184,000 United States dollar
Amphenol total assets: 3,219,184,000 United States dollar, claim clm_085C32D5AEE2 · ended · superseded by clm_521FF51179A1 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Amphenol · research and development · 647,000,000 United States dollar
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amphenol · quarterly net income · 1,769,200,000 United States dollar
Amphenol quarterly net income: 1,769,200,000 United States dollar, claim clm_08E3D8BDF073 · ended · superseded by clm_9481E7C9E845 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amphenol · shares outstanding · 305,339,096 shares
Amphenol shares outstanding: 305,339,096 shares, claim clm_097AA3BAD121 · ended · superseded by clm_B13E6D6AC202 · 1 source (1 primary) · conf 0.95

What the statuses mean